Anti-Human IL6 Therapeutic Antibody (Siltuximab)
Recombinant monoclonal antibody to IL-6. Siltuximab (INN) (also known as CNTO 328, Anti-IL-6 chimeric monoclonal antibody or cCLB8) is a chimeric (made from human and mouse proteins) monoclonal antibody. It binds to interleukin-6. Siltuximab has been investigated for the treatment of metastatic renal cell cancer, prostate cancer, and Castleman's disease, among other types of cancer.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-212 |
| Pricing | Inquiry |
| Host | Mouse |
| Target | IL-6 |
| Species Reactivity | Human |
| Type | IgG1 - kappa |
| Applications | IF, IP, Neut, FuncS, ELISA, FC, ICC |
| Storage | Store it under sterile conditions at -20°C upon receiving. Recommend to pack the protein into smaller quantities for optimal storage. |